News Room

Advancing Digital Transformation and Market Leadership

Driving Strategic Expansion with Solid Growth

 

(Hong Kong —— September 25,2025) Human Health Holdings Limited (“Human Health” or the “Company”, together with its subsidiaries, the “Group”; stock code: 1419), a leading private integrated healthcare service provider in Hong Kong, announces  its consolidated annual results for the year ended 30 June 2025 (the “FY2025”).

 

The Group concluded a year of significant strategic progress and solid financial performance. By executing its strategy of operational excellence, strategic market expansion —and accelerated digital transformation, Human Health has strengthened its core businesses and delivered sustainable value to its shareholders and the community.

 

Financial Performance

• Revenue Growth: The Group's revenue for FY2025 was approximately HK$644.4 million, representing an increase of approximately 9.1% as compared with that for FY2024. This growth was mainly driven by the increased revenue from general practice services ,specialties services and dental services.
• Profit Growth: The profit attributable to owners of the Company for FY2025 was approximately HK$26.3 million, representing an increase of approximately HK$2.1 million or 8.9% as compared to approximately HK$24.2 million for FY2024.

• Earnings Per Share: Basic earnings per share for FY2025 amounted to approximately HK6.9 cents (FY2024: approximately HK6.4 cents).

• Dividend: The Board proposed declaration of final dividend of HK3.0 cents for FY2025 (FY2024: HK2.8 cents).

 

 

Business Segment Performanc

1. General Practice Segment

• Revenue reached HK$ 410.8 million, recorded a year- on- year growth of approximately 3.1%.

• The growth was primarily driven by a strategic network expansion with the opening of new medical centres in key districts. This expansion improved accessibility and consolidated the Group's presence, leading to an increase in the revenue.

 

2. Specialties Segment

• Revenue reached HK$ 165.8 million, recorded a year-on-year growth of approximately 23.8%.

• The growth was particularly strong in ophthalmology under the POLYEYE brand which enhanced its service capacities and coverage by engaging more ophthalmologists and optometrists, and strengthened its portfolio with sophisticated treatments.
• POLYEYE further solidified its reputation as a trusted leader in specialised eye health through its deep commitment to social responsibility. This included launching the ‘Eye Caring for the Elderly’ campaign by donating cataract surgery quotas which worth over HK$2 million and actively participating in key Public-Private Partnership Programmes such as the “Cataract Surgeries Programme” and “Glaucoma Public-Private Partnership Programme”, providing vital options to patients on public waiting lists.

 

3. Dental Segment

• Revenue reached HK$ 67.8 million, recorded a year- on- year gowth of approximately 15.9%.

• The growth was primarily due to increased patient visits following the acquisition of Monarch Dental Clinic Limited. This strategic acquisition expanded the patient reach and strengthened the Group’s footprint in the dental healthcare market.
• The acquisition of Monarch Dental with established brand, experienced dental practitioners, and complementary service mix is expected to create cross-referral and collaboration opportunities across the Group's platforms.

 

Development of Healthy Square H2
Healthy Square H2 in Tsim Sha Tsui continued to develop as an integrated health hub, offering comprehensive medical and wellness services. The Wehealth Day Procedure Centre inside Health Square introduced and covered more surgical procedures that do not require hospitalization, provided an alternative cost-effecitve, convenient option to our patients with better experience, increased the overall service demand and volume.

The community pharmacy provided essential pharmaceutical products and medication consultancy services. Preventive care remained a key focus of the Group. The Group continued to actively promote advanced diagnostic check-up packages and educational seminars through Impact Health at Healthy Square H2. These efforts reinforced the Group's commitment to proactive health management and long-term wellness.

 

Expanded Digital Platforms and Customer Engagement

The Group made substantial progress in digital transformation, including the implementation of its integrated clinical operating system and an omnichannel messaging platform. A queuing system with a dedicated queue for elderly patients was rolled out in most centres, streamlining service flow and enhancing satisfaction. These improvements exemplify the Group’s commitment to embedding technology across operations to enhance care quality and efficiency.

 

Mr. Chan Kin Ping, BBS, JP said “FY2025 was a year of remarkable achievement for Human Health. Despite market challenges, we delivered strong financial performance, completed a synergistic acquisition, and advanced our digital capabilities. Our team's dedication to person-centered care and operational excellence has been instrumental in our success. We are particularly proud of our partnerships with the Hong Kong Government through various public health initiatives and our active cooperation in developing the connection with the comprehensive healthcare information infrastructure. As we move forward, we remain committed to expanding our services, deepening these strategic collaborations, and leveraging technology to enhance healthcare services to the people of Hong Kong.”

 

Business Outlook

Looking ahead, the Group maintains a cautiously optimistic outlook for the healthcare sector, anticipating sustained demand driven by demographic trends and growing health awareness. Building on the foundations laid in FY2025, the Group will pursue strategic expansion through carefully selected locations, enhanced specialties capabilities particularly in eye care under the POLYEYE brand, and full integration of the Monarch Dental acquisition. The Group will further leverage its Day Procedure Centre at Healthy Square and continue to introduce and perform more surgical procedures that do not require hospitalization, improving both operational efficiency and patient experience.

 

The Group remains committed to technological advancement, with plans to explore innovative solutions in telehealth and data management to deliver more seamless, person-centric experiences. Furthermore, the Group will continue to invest in talent development across all disciplines to attract and retain skilled professionals. The Group will also strengthen its partnerships with the Hong Kong Government on public health initiatives and collaborate on the development of the connectivity with the healthcare information infrastructure. Through these coordinated strategies, the Group is well-positioned to navigate market challenges, capture emerging opportunities, and deliver sustainable value to all stakeholders while advancing its mission of providing comprehensive, person-focused healthcare services.

 

- END –

 

About Human Health Holdings Limited

Human Health, listed on the Main Board of the Hong Kong Stock Exchange (Stock Code: 1419), is one of the largest medical groups in Hong Kong. Having been serving the community since 1997, the Group operates more than 60 medical centres, with more than 800 professional team members and staff. With an aim to ”Elevate Your Health Values, Elevate Your Life", Human Health provides comprehensive medical services network including general practice, specialties, dental, eye care, physiotherapy, diagnostics & imaging, day procedure and endoscopy, medical aesthetics, Chinese medicine, outreach, rehabilitation and case management, wellness and retail services to provide professional and person-centered care medical and wellness services in Hong Kong.

 

Media Enquiries:

China Times Corporate Advisory Limited

Destiny Cheng

Tel: (852) 6220 0861

Email: pr@ctimes.hk

Fax: (852) 3428 3012